Acquired cutis laxa secondary to Sweet syndrome in a child (Marshall syndrome): A rare case report.

Autor: Jagati A; Department of Dermatology, N.H.L. Medical College, Ahmedabad, Gujarat, India., Shrivastava S; Department of Dermatology, Index Medical College, Indore, Madhya Pradesh, India., Baghela B; Practicing Dermatologist, Independent Researcher, Ujjain, Madhya Pradesh, India., Agarwal P; Department of Dermatology, N.H.L. Medical College, Ahmedabad, Gujarat, India., Saikia S; Department of Dermatology, N.H.L. Medical College, Ahmedabad, Gujarat, India.
Jazyk: angličtina
Zdroj: Journal of cutaneous pathology [J Cutan Pathol] 2020 Feb; Vol. 47 (2), pp. 146-149. Date of Electronic Publication: 2019 Aug 30.
DOI: 10.1111/cup.13567
Abstrakt: Sweet syndrome is rare in the pediatric population and usually responds well to treatment, resolving without sequelae. Marshall syndrome is a rare pediatric skin disease characterized by loss of elastic tissue (cutis laxa) secondary to acquired, localized neutrophilic dermatitis without any internal organ involvement. Only few cases of Marshall syndrome (acquired cutis laxa type II) have been reported. Systemic steroids and dapsone show excellent results in Sweet syndrome. Although there is no satisfactory treatment for cutis laxa, dapsone can be used in the acute phase for control of swelling.
(© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje